This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Assistance Publique-Hopitaux De Paris, National Institute of Health and Medical Research, Université Paris Diderot-Paris 7. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 331 
2 out of 1,853 
2 out of 111 
Years Active: 2020-2021
Title: The Innovative Contributions of Inventor Jean-Damien Ricard
Introduction
Jean-Damien Ricard, an accomplished inventor based in Paris, France, has made significant strides in the field of medical science. With a total of two patents to his name, his work is focused on addressing critical healthcare challenges, particularly concerning antibiotic resistance and bacterial infections.
Latest Patents
Ricard's latest innovations include a groundbreaking bacteriophage strain designed to combat the ST131-025b:H4 clone, which is increasingly responsible for human community and hospital-acquired infections. This invention showcases a high degree of specificity, targeting 025b strains with remarkable efficacy while demonstrating 70% coverage on the two major antibiotic-resistant clonal complexes, ST131-025b:H4 and ST69-025b. The bacteriophage LM33_P1 was evaluated using various in vivo models, proving its ability to infect bacteria across different organs.
Another significant patent involves the use of cranberry-derived proanthocyanidin extract as a method for preventing Gram-negative bacterial colonization of oropharyngeal material. This innovative approach offers a potential solution to bacterial colonization challenges, underscoring Ricard's commitment to advancing medical treatment protocols.
Career Highlights
Jean-Damien Ricard's professional journey includes pivotal roles at prominent institutions like the Institut National de la Santé et de la Recherche Médicale and Assistance Publique—Hôpitaux de Paris. His expertise in bacteriophage research and bacterial infections has positioned him at the forefront of innovations in public health.
Collaborations
Throughout his career, Ricard has collaborated with notable individuals in the field, including Olivier Clermont and Laurent Debarbieux. These partnerships have facilitated the sharing of knowledge and resources, further enhancing the impact of his inventions.
Conclusion
In summary, Jean-Damien Ricard stands out as a visionary inventor dedicated to tackling pressing health issues through innovative solutions. His contributions, particularly in the realm of bacteriophage research and bacterial colonization prevention, mark significant advancements in medical science. As antibiotic resistance continues to be a global concern, the importance of his work cannot be overstated, promising a brighter future in infectious disease management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile